Supported by the Singapore National Eye Centre, Singapore Eye Research Institute and the National Health Innovation Centre, Plano is an award-winning company tackling the myopia epidemic through innovative technology solutions.
Through Thomson X, Plano’s digital eye-care solutions will be made available to patients across Thomson Medical Centre in Singapore and Malaysia. The partnership also allows Plano to expand into the growing esports arena — a high-risk space for myopia — with Thomson X’s network in the Global Esports Federation.
Plano’s Founding Managing Director, Associate Professor Mohamed Dirani, is an Adjunct Associate Professor at Duke-NUS Medical School and an Honorary Principal Investigator at the Singapore Eye Research Institute (SERI) and the Centre for Eye Research Australia (CERA).
In July 2020, Plano announced its strategic alliance with global ophthalmic leader, Santen Pharmaceutical.